This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Pets at Home investor expects little impact from UK veterinary market probe

By Jon Menon ( November 12, 2024, 11:40 GMT | Insight) -- Pets at Home Group investor Schroder Income Growth Fund said it doesn’t expect ongoing UK antitrust scrutiny of the veterinary sector to cause “substantive adverse outcomes” for the company and that it hasn’t seen evidence of abusive charging practices within the business. There has been pressure on the company's shares in the wake of the Competition and Markets Authority's market probe, scheduled to wrap up in 12 months' time.Pets at Home Group investor Schroder Income Growth Fund said it doesn’t expect ongoing UK antitrust scrutiny of the veterinary sector to cause “substantive adverse outcomes” for the company and that it hasn’t seen evidence of abusive charging practices within the business....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections